CANCER THERAPEUTICS

OSL’s Pancreatic Cancer Treatment Approved for Sale in Europe

May 5, 2020

OncoSil Medical (ASX:OSL) has received CE Mark approval to market and sell its breakthrough implantable radiotherapy treatment for pancreatic cancer in the EU and UK.